
Publication
2023 Annual Litigation Trends Survey
Norton Rose Fulbright has released its 2023 Annual Litigation Trends Survey, analyzing litigation trends across the legal landscape.
We use cookies and other similar technology to collect data about you to allow us to deliver our online services, measure our website audience and improve your browsing experience. Full details on the cookies we use are set out in our Cookies policy. Please click OK to signify your consent to our use of cookies.
You can withdraw your consent by clicking “manage cookies” and following the instructions shown.
United States | Publication | November 8, 2021
On November 6, 2021, the Fifth Circuit Court of Appeals granted a nationwide stay of the Occupational Health and Safety Administration (OSHA)'s Emergency Temporary Standard (ETS) vaccine-or-test mandate that was issued on November 5, 2021. The court granted the nationwide stay due to "grave statutory and constitutional issues" with the mandate.
The emergency stay was requested by numerous petitioners, including the Attorneys General for the states of Texas, Louisiana, Mississippi, South Carolina, Utah and several private entities. The federal government must respond to the petitioners' motion for a permanent injunction by 5:00 pm today, to which petitioners may file their reply brief by 5:00 pm tomorrow, Tuesday, November 9, 2021.
Until the courts provide further notice, employers need not begin enforcing OSHA's vaccine-or-test mandate.
Special thanks to law clerk Michelle Avidisyans (Los Angeles) for her assistance in the preparation of this content.
Publication
Norton Rose Fulbright has released its 2023 Annual Litigation Trends Survey, analyzing litigation trends across the legal landscape.
Publication
British Columbia has announced that, following 2021’s Yahey v British Columbia decision, it has reached agreements with five Treaty 8 First Nations over the province’s management of natural resources.
Subscribe and stay up to date with the latest legal news, information and events...
© Norton Rose Fulbright LLP 2023